MESCHIARI, MARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 5.175
EU - Europa 4.083
AS - Asia 1.071
SA - Sud America 53
AF - Africa 18
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.415
Nazione #
US - Stati Uniti d'America 5.067
IT - Italia 1.893
GB - Regno Unito 816
SE - Svezia 429
CN - Cina 280
SG - Singapore 269
DE - Germania 240
HK - Hong Kong 234
FI - Finlandia 132
FR - Francia 116
CA - Canada 103
BG - Bulgaria 76
ID - Indonesia 71
RU - Federazione Russa 58
LT - Lituania 49
IR - Iran 48
TR - Turchia 45
IN - India 43
NL - Olanda 38
IE - Irlanda 33
ES - Italia 32
SI - Slovenia 30
UA - Ucraina 30
CZ - Repubblica Ceca 25
VN - Vietnam 24
BE - Belgio 20
MY - Malesia 17
CO - Colombia 14
CL - Cile 12
RO - Romania 12
AR - Argentina 11
BR - Brasile 11
PL - Polonia 10
CH - Svizzera 9
AU - Australia 8
JP - Giappone 8
EG - Egitto 6
GR - Grecia 6
TH - Thailandia 6
ZA - Sudafrica 6
PH - Filippine 5
PK - Pakistan 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
EU - Europa 3
HU - Ungheria 3
LV - Lettonia 3
MD - Moldavia 3
MK - Macedonia 3
PT - Portogallo 3
SD - Sudan 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
BZ - Belize 2
HR - Croazia 2
IL - Israele 2
KR - Corea 2
KZ - Kazakistan 2
MC - Monaco 2
NI - Nicaragua 2
NO - Norvegia 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
IQ - Iraq 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MA - Marocco 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 10.415
Città #
Fairfield 779
Southend 653
Chandler 638
Ashburn 562
Nyköping 333
Woodbridge 302
Cambridge 288
Houston 277
Seattle 259
Hong Kong 226
Wilmington 207
Singapore 185
Modena 147
New York 142
San Diego 137
Rome 125
Bologna 121
Milan 116
Ann Arbor 114
Helsinki 114
Princeton 76
Jakarta 67
Sofia 67
Beijing 55
Bremen 55
London 54
Parma 48
Shanghai 47
Dearborn 43
Jacksonville 43
Toronto 43
North York 37
Redwood City 36
Fremont 33
Naples 33
Reggio Emilia 33
Munich 29
Boardman 28
Dublin 25
Catania 22
Chicago 21
Grafing 21
Des Moines 20
Dong Ket 20
Florence 20
Izmir 20
Los Angeles 20
Brno 19
Falls Church 18
Tabriz 18
Brussels 17
Reggio Nell'emilia 17
Madrid 16
Palermo 16
Verona 16
Bari 15
Norwalk 15
Paris 15
Amsterdam 14
Beauharnois 14
Frankfurt am Main 14
Rimini 14
Turin 14
Bergamo 13
Padova 13
Roncoferraro 13
Bagnacavallo 12
Eugene 12
San Jose 12
Chiswick 10
Córdoba 10
Lappeenranta 10
Nanjing 10
Kilburn 9
Mumbai 9
Washington 9
Brescia 8
Buffalo 8
Dallas 8
Genoa 8
Hounslow 8
Ravenna 8
Trieste 8
Carpi 7
Milwaukee 7
Murcia 7
Phoenix 7
Rho 7
Santiago 7
Vicenza 7
Bogotá 6
Castelnuovo Rangone 6
Chengdu 6
Desio 6
Hamm 6
Livorno 6
Prescot 6
San Mateo 6
Sassuolo 6
Treviso 6
Totale 7.300
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 671
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 371
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 336
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 294
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 282
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 266
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 256
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 246
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 230
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 210
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 208
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 205
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 198
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 195
Ectopic fat is linked to prior cardiovascular events in men with HIV. 193
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 178
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 176
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 171
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 169
Hypokalemia in Patients with COVID-19 162
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 154
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 149
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 141
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 140
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 137
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 134
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 132
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 129
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 128
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 127
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 126
Peritoneal dialysis in the time of coronavirus disease 2019 126
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 126
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 118
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 118
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 117
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection 116
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 114
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 110
Metabolic reprograming shapes neutrophil functions in severe COVID-19 110
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 109
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 106
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 106
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 104
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 103
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 101
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 100
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 95
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) 89
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 83
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 83
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 79
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 77
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 76
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 75
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae 74
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 74
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 74
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 71
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 66
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 65
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 64
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 62
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 59
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 56
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 51
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 51
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 49
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 49
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 48
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 47
Continued decay of HIV proviral DNA upon vaccination with HIV-1 Tat of subjects on long-term ART: An 8-year follow-up study 47
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 46
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 45
Re: 'methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al 44
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 43
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab 42
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 42
Do all critically ill patients with COVID-19 disease benefit from adding tocilizumab to glucocorticoids? A retrospective cohort study. 41
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 34
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 32
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 31
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 29
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 24
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 22
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 21
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) 20
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 19
Reduction trend of mcr-1 circulation in Emilia-Romagna Region, Italy 19
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 18
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 18
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 15
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 15
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: The SALIR-E Study 15
Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU 13
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 9
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 8
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 8
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 6
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 6
Totale 10.647
Categoria #
all - tutte 60.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020499 0 0 0 38 47 76 82 58 49 57 48 44
2020/20212.197 108 145 93 182 186 149 347 199 175 171 249 193
2021/20222.228 149 141 167 69 114 148 266 122 232 160 406 254
2022/20232.405 272 293 195 215 238 272 74 203 278 71 140 154
2023/20242.281 89 135 163 194 374 222 174 256 104 105 181 284
2024/2025558 198 120 133 107 0 0 0 0 0 0 0 0
Totale 10.647